71 related articles for article (PubMed ID: 22494724)
1. Re: towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal.
Richie JP
J Urol; 2012 May; 187(5):1644. PubMed ID: 22494724
[No Abstract] [Full Text] [Related]
2. Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal.
Necchi A; Colecchia M; Nicolai N; Piva L; Catanzaro M; Biasoni D; Torelli T; Stagni S; Paolini B; Milani A; Salvioni R
BJU Int; 2011 Apr; 107(7):1088-94. PubMed ID: 20868391
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):173-8. PubMed ID: 18823690
[TBL] [Abstract][Full Text] [Related]
4. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases.
Comiter CV; Kibel AS; Richie JP; Nucci MR; Renshaw AA
J Urol; 1998 Mar; 159(3):859-63. PubMed ID: 9474169
[TBL] [Abstract][Full Text] [Related]
5. [Malignant transformation of thyroid tissue in an ovarian dermoid cyst: case report].
Krnojelac D; Hadzić B; Curcin N; Dolai M; Bogdanović G
Med Pregl; 1999; 52(9-10):395-8. PubMed ID: 10624391
[TBL] [Abstract][Full Text] [Related]
6. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognostic factors of malignant ovarian teratoma].
Jin FM; Zhu GZ; Feng YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088
[TBL] [Abstract][Full Text] [Related]
8. Malignant steroidogenic tumor arising from sacrococcygeal mature teratoma.
Yoshida M; Tanaka M; Gomi K; Ohama Y; Kigasawa H; Iwanaka T; Tanaka Y
Hum Pathol; 2011 Oct; 42(10):1568-72. PubMed ID: 21497366
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation in mature cystic teratoma of the ovary: report of five cases and review of the literature.
Bal A; Mohan H; Singh SB; Sehgal A
Arch Gynecol Obstet; 2007 Mar; 275(3):179-82. PubMed ID: 16957908
[TBL] [Abstract][Full Text] [Related]
11. An unusual case of giant mediastinal teratoma with malignant transformation.
Chen C; Zheng H; Jiang S
Ann Thorac Surg; 2008 Jul; 86(1):302-4. PubMed ID: 18573447
[TBL] [Abstract][Full Text] [Related]
12. Unilateral malignant struma ovarii in a case of bilateral ovarian teratoma with raised CA-125 level: a rare case with treatment dilemmas.
Menon S; Deodhar K; Rekhi B; John A; Maheshwari A
Indian J Pathol Microbiol; 2011; 54(3):578-80. PubMed ID: 21934226
[TBL] [Abstract][Full Text] [Related]
13. [Malignant degeneration of mature benign teratoma of the ovary: a case report].
Aïda AK; Sana BS; Essia S; Carole GB; Ahlem LB; Amel T; Sabah MR
Tunis Med; 2005 Nov; 83(11):710-3. PubMed ID: 16422372
[TBL] [Abstract][Full Text] [Related]
14. [Mediastinal teratoma with malignant transformation of the somatic component. Clinical report].
Gerardo R; Morgado C; Calvo D; Pinto E; Bravio I; Castelão N; Martelo F
Rev Port Cir Cardiotorac Vasc; 2009; 16(3):143-7. PubMed ID: 20140289
[TBL] [Abstract][Full Text] [Related]
15. Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Yamagami W; Banno K; Kawaguchi M; Yanokura M; Kuwabara Y; Hirao N; Susumu N; Tsukazaki K; Aoki D
Chemotherapy; 2007; 53(2):137-41. PubMed ID: 17308380
[TBL] [Abstract][Full Text] [Related]
16. [Non-seminomatous germ cell tumors of the testis. Role of the pathologist in the assessment of prognostic factors based on the specimen of orchiectomy. Proposal of an anatomopathological examination report defined by the Study Group of the Committee of Cancerology of the French Association of Urology].
Barbagelatta M; Berger N; Boccon-Gibod L; Bouvier R; Deslignières S; Escourrou G; Lesourd A; Mazerolles C; Schill H; Terrier-Lacombe MJ
Arch Anat Cytol Pathol; 1994; 42(2):83-90. PubMed ID: 7811119
[TBL] [Abstract][Full Text] [Related]
17. Cerebral mature teratoma with malignant transformation in a 52-year-old man: a case report.
Kiyuna M; Toda T; Gushiken M; Okuyama K; Yamashiro K
Rinsho Byori; 2006 Mar; 54(3):221-5. PubMed ID: 16637568
[TBL] [Abstract][Full Text] [Related]
18. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution.
Sanfilippo R; Miceli R; Grosso F; Fiore M; Puma E; Pennacchioli E; Barisella M; Sangalli C; Mariani L; Casali PG; Gronchi A
Ann Surg Oncol; 2011 Mar; 18(3):720-5. PubMed ID: 20878245
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of an ovarian mature cystic teratoma presenting as a rectal mass.
Lee YC; Abulafia O; Montalto N; Holcomb K; Matthews R; Golub RW
Gynecol Oncol; 1999 Dec; 75(3):499-503. PubMed ID: 10600316
[TBL] [Abstract][Full Text] [Related]
20. Combined modality treatment for malignant transformation of a benign ovarian teratoma.
Kurtz JE; Jaeck D; Maloisel F; Jung GM; Chenard MP; Dufour P
Gynecol Oncol; 1999 May; 73(2):319-21. PubMed ID: 10329054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
